These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22579111)

  • 1. Interleukin-6 and matrix metalloproteinase expression in the subretinal fluid during proliferative vitreoretinopathy: correlation with extent, duration of RRD and PVR grade.
    Symeonidis C; Papakonstantinou E; Androudi S; Tsaousis KT; Tsinopoulos I; Brazitikos P; Karakiulakis G; Diza E; Dimitrakos SA
    Cytokine; 2012 Jul; 59(1):184-90. PubMed ID: 22579111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of interleukin-6 and matrix metalloproteinase expression in the subretinal fluid and the vitreous during proliferative vitreoretinopathy: correlations with extent, duration of RRD and PVR grade.
    Symeonidis C; Papakonstantinou E; Androudi S; Georgalas I; Rotsos T; Karakiulakis G; Diza E; Dimitrakos SA
    Cytokine; 2014 Jun; 67(2):71-6. PubMed ID: 24725542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of matrix metalloproteinase levels with the grade of proliferative vitreoretinopathy in the subretinal fluid and vitreous during rhegmatogenous retinal detachment.
    Symeonidis C; Papakonstantinou E; Souliou E; Karakiulakis G; Dimitrakos SA; Diza E
    Acta Ophthalmol; 2011 Jun; 89(4):339-45. PubMed ID: 19764916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinases in the subretinal fluid correlates with the extent of rhegmatogenous retinal detachment.
    Symeonidis C; Diza E; Papakonstantinou E; Souliou E; Karakiulakis G; Dimitrakos SA
    Graefes Arch Clin Exp Ophthalmol; 2007 Apr; 245(4):560-8. PubMed ID: 16941143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of the extent and duration of rhegmatogenous retinal detachment with the expression of matrix metalloproteinases in the vitreous.
    Symeonidis C; Diza E; Papakonstantinou E; Souliou E; Dimitrakos SA; Karakiulakis G
    Retina; 2007; 27(9):1279-85. PubMed ID: 18046238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 and the matrix metalloproteinase response in the vitreous during proliferative vitreoretinopathy.
    Symeonidis C; Papakonstantinou E; Androudi S; Rotsos T; Diza E; Brazitikos P; Karakiulakis G; Dimitrakos SA
    Cytokine; 2011 May; 54(2):212-7. PubMed ID: 21353595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipokine levels in subretinal fluid from patients with rhegmatogenous retinal detachment.
    Ricker LJ; Kijlstra A; Kessels AG; de Jager W; Hendrikse F; La Heij EC
    Exp Eye Res; 2012 Jan; 94(1):56-62. PubMed ID: 22138416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine levels in subretinal fluid obtained during scleral buckling surgery after rhegmatogenous retinal detachment.
    Ricker LJ; Kijlstra A; de Jager W; Liem AT; Hendrikse F; La Heij EC
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4143-50. PubMed ID: 20335622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine CXCL-1 expression in the subretinal fluid during rhegmatogenous retinal detachment.
    Symeonidis C; Androudi S; Rotsos T; Moschos MM; Souliou E; Dimitrakos SA; Diza E
    Ocul Immunol Inflamm; 2014 Dec; 22(6):449-53. PubMed ID: 24354433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Chemokine CXCL-1 and Interleukin-6 Concentrations in the Subretinal Fluid and Vitreous in Rhegmatogenous Retinal Detachment.
    Symeonidis C; Rotsos T; Matsou A; Dermenoudi M; Georgalas I; Tsinopoulos I; Makri O; Souliou E; Dimitrakos SA
    Ocul Immunol Inflamm; 2021 Feb; 29(2):355-361. PubMed ID: 31661651
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemokine CXCL-1: activity in the vitreous during proliferative vitreoretinopathy.
    Symeonidis C; Androudi S; Georgalas I; Tzamalis A; Chalvatzis N; Rotsos T; Souliou E; Diza E; Dimitrakos SA
    Clin Exp Immunol; 2015 Aug; 181(2):338-42. PubMed ID: 25766782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of proliferative vitreoretinopathy after retinal detachment surgery: potential of biomarker profiling.
    Ricker LJ; Kessels AG; de Jager W; Hendrikse F; Kijlstra A; la Heij EC
    Am J Ophthalmol; 2012 Aug; 154(2):347-354.e2. PubMed ID: 22541653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100b protein levels in subretinal fluid in rhegmatogenous retinal detachment.
    Yalcinbayir O; Buyukuysal RL; Akova-Budak B; Gelisken O
    Curr Eye Res; 2012 Nov; 37(11):1030-5. PubMed ID: 22671138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominance of MMP-1 and MMP-2 in epiretinal and subretinal membranes of proliferative vitreoretinopathy.
    Webster L; Chignell AH; Limb GA
    Exp Eye Res; 1999 Jan; 68(1):91-8. PubMed ID: 9986746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intercellular adhesion molecule-1 in proliferative vitreoretinopathy.
    Limb GA; Chignell AH; Cole CJ; Green WT; Webster L; Hollifield RD; Dumonde DC
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1043-8. PubMed ID: 9113001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.
    Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
    Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble apoptotic factors and adhesion molecules in rhegmatogenous retinal detachment.
    Ricker LJ; Altara R; Goezinne F; Hendrikse F; Kijlstra A; La Heij EC
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4256-62. PubMed ID: 21372012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional retinal surgery for rhegmatogenous retinal detachment with proliferative vitreoretinopathy.
    Ivanisević M
    Acta Med Croatica; 1995; 49(4-5):207-9. PubMed ID: 8630455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study.
    Kon CH; Occleston NL; Aylward GW; Khaw PT
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):705-12. PubMed ID: 10067974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy.
    Kon CH; Occleston NL; Charteris D; Daniels J; Aylward GW; Khaw PT
    Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1524-9. PubMed ID: 9660504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.